ArticleOncotarget2017

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.

Egor Bobrov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.